GeneDx Holdings (WGS) Capital Expenditures Growth (1y) (2021 - 2026)
GeneDx Holdings (WGS) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn | 53.06% |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn | 8.47% |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn | -27.73% |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn | -33.33% |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn | 31.13% |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn | 1.48% |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn | 33.33% |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn | 16.40% |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn | 27.78% |
| 10 | GeneDx Holdings | 2.08 Bn | 1.94 Bn | 78.24 Mn | 326.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 326.93% |
| Mar 31, 2026 | -3.49% |
| Dec 31, 2025 | -97,700.00% |
| Sep 30, 2025 | 192.37% |
| Jun 30, 2025 | 3,984.48% |
| Mar 31, 2025 | 1,283.52% |
| Dec 31, 2024 | 98.62% |
| Sep 30, 2024 | 236.90% |
| Jun 30, 2024 | -97.90% |
| Dec 31, 2023 | -119.36% |
| Sep 30, 2023 | -28.29% |
| Jun 30, 2023 | 101.61% |
| Dec 31, 2022 | 170.23% |
| Sep 30, 2022 | -146.34% |
| Jun 30, 2022 | -66.42% |
| Mar 31, 2022 | -33.59% |
| Dec 31, 2021 | -4,562.57% |